China Universal Asset Management Co., Ltd. Atea Pharmaceuticals, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.05 Billion
- Q1 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 16,942 shares of AVIR stock, worth $54,044. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,942
Previous 17,909
5.4%
Holding current value
$54,044
Previous $59,000
15.25%
% of portfolio
0.0%
Previous 0.01%
Shares
16 transactions
Others Institutions Holding AVIR
# of Institutions
109Shares Held
48.3MCall Options Held
3.4KPut Options Held
14.5K-
Black Rock Inc. New York, NY9.12MShares$29.1 Million0.0% of portfolio
-
Bml Capital Management, LLC Zionsville, IN7.61MShares$24.3 Million18.41% of portfolio
-
Tang Capital Management LLC San Diego, CA4.8MShares$15.3 Million0.93% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$15.1 Million0.0% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA2.49MShares$7.93 Million2.49% of portfolio
About Atea Pharmaceuticals, Inc.
- Ticker AVIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,258,600
- Market Cap $266M
- Description
- Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...